<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>NitroMed RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>NitroMed Reports Financial Results for Fourth Quarter and Full Year 2008</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Reports-Financial-Results-for-Fourth-Quarter-and-Full-Year-2008-458190</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwcellpaddingbottom1 {padding-bottom: 2.0px}
.bwcellpaddingbottom3 {padding-bottom: 4.0px}
.bwcellpaddingleft0 {padding-left: 0.0px}
.bwcellpaddingleft10 {padding-left: 50.0px}
.bwcellpaddingleft4 {padding-left: 20.0px}
.bwcellpaddingright0  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Reports-Financial-Results-for-Fourth-Quarter-and-Full-Year-2008-458190</guid></item><item><title>NitroMed Special Meeting of Stockholders Further Adjourned Today to Consider Higher Bid From Deerfield Management</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Special-Meeting-of-Stockholders-Further-Adjourned-Today-to-Consider-Higher-Bid-From-Deerfield-Management-432970</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      The board of directors of NitroMed, Inc. (NASDAQ: NTMD) further 
      adjourned its special meeting of stockholders, scheduled to be 
      reconvened  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Special-Meeting-of-Stockholders-Further-Adjourned-Today-to-Consider-Higher-Bid-From-Deerfield-Management-432970</guid></item><item><title>NitroMed Special Meeting of Stockholders Adjourned Today to Consider Higher Bid From Deerfield Management</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Special-Meeting-of-Stockholders-Adjourned-Today-to-Consider-Higher-Bid-From-Deerfield-Management-430829</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      The board of directors of NitroMed, Inc. (NASDAQ: NTMD) adjourned its 
      special meeting of stockholders, scheduled for today to approve the sale 
  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Special-Meeting-of-Stockholders-Adjourned-Today-to-Consider-Higher-Bid-From-Deerfield-Management-430829</guid></item><item><title>NitroMed Receives Revised Unsolicited Acquisition Proposal from Deerfield Management</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Revised-Unsolicited-Acquisition-Proposal-from-Deerfield-Management-429631</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      NitroMed, Inc. (NASDAQ: NTMD) said today that on Friday, January 9, 
      2009, NitroMed received a letter from Deerfield Management increasing 
       ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Revised-Unsolicited-Acquisition-Proposal-from-Deerfield-Management-429631</guid></item><item><title>NitroMed Confirms Receipt of Letter from Deerfield Management</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Confirms-Receipt-of-Letter-from-Deerfield-Management-423508</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      NitroMed, Inc. (NASDAQ: NTMD) said today that Deerfield Management has 
      responded to NitroMed’s communication regarding the company’s 
      willingness  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Confirms-Receipt-of-Letter-from-Deerfield-Management-423508</guid></item><item><title>NitroMed Receives Unsolicited Acquisition Proposal from Deerfield Management</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Unsolicited-Acquisition-Proposal-from-Deerfield-Management-417660</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      NitroMed, Inc. (NASDAQ: NTMD) said today that it has received an 
      unsolicited proposal from Deerfield Management to acquire the company 
      for  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Unsolicited-Acquisition-Proposal-from-Deerfield-Management-417660</guid></item><item><title>NitroMed and Archemix Announce Merger Agreement</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-and-Archemix-Announce-Merger-Agreement-410995</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      NitroMed, Inc. (NASDAQ: NTMD) and Archemix Corp., a privately-held 
      biopharmaceutical company working to develop aptamer-based therapeutics, 
     ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-and-Archemix-Announce-Merger-Agreement-410995</guid></item><item><title>NitroMed Announces Agreement to Sell BiDil(R) Drug Business to JHP Pharmaceuticals, LLC</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Announces-Agreement-to-Sell-BiDil-R-Drug-Business-to-JHP-Pharmaceuticals-LLC-397174</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwcellpaddingbottom1 {padding-bottom: 2.0px}
.bwcellpaddingbottom3 {padding-bottom: 4.0px}
.bwcellpaddingleft0 {padding-left: 0.0px}
.bwcellpaddingright0 {padding-right: 0.0px}
.bwcellparagraphmargin {margin-bottom: 0px;  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Announces-Agreement-to-Sell-BiDil-R-Drug-Business-to-JHP-Pharmaceuticals-LLC-397174</guid></item><item><title>NitroMed Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ's Minimum Bid Price Requirement</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Notification-from-NASDAQ-Regarding-Non-Compliance-with-NASDAQ-s-Minimum-Bid-Price-Requirement-380501</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      NitroMed, Inc. (NASDAQ: NTMD) reported that on September 16, 2008 it 
      received a letter from The &lt;a  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Receives-Notification-from-NASDAQ-Regarding-Non-Compliance-with-NASDAQ-s-Minimum-Bid-Price-Requirement-380501</guid></item><item><title>NitroMed Reports Financial Results for Second Fiscal Quarter 2008</title><link>http://www.finanzen.net/nachricht/aktien/NitroMed-Reports-Financial-Results-for-Second-Fiscal-Quarter-2008-364038</link><description>NitroMed, Inc. (NASDAQ: NTMD) today reported financial results for its 
      second fiscal quarter and year to date ended June 30, 2008. NitroMed is 
      the maker of BiDil® 
      (isosorbide dinitrate/hydralazine hydrochloride), an orally administered  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/NitroMed-Reports-Financial-Results-for-Second-Fiscal-Quarter-2008-364038</guid></item></channel></rss>

